A pilot study on the use of serum glyoxalase as a supplemental biomarker to predict malignant cases of the prostate in the PSA range of 4-20 ng/ml

por Chavan, Sushant V., Chavan, Niraj R., Balaji, Anusha, Trivedi, Vatsala D., Chavan, Padma R.
Publicado 2011